HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Extract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sone, H. Search for Related Content PubMed PubMed Citation Articles by Sone, H. Social Bookmarking                What's this?

The New Worldwide Definition of Metabolic Syndrome Is Not a Better Diagnostic Predictor of Cardiovascular Disease in Japanese Diabetic Patients Than the Existing Definitions

Additional analysis from the Japan Diabetes Complications Study

¹ Department of Internal Medicine, University of Tsukuba Institute of Clinical Medicine, Tsukuba, Japan
² Statistics and Cancer Control Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan
³ Department of Endocrinology and Metabolism, Jichi Medical College, Tochigi, Japan
⁴ Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, Osaka, Japan
⁵ Department of Medicine, Nippon Medical School, Tokyo, Japan
⁶ Tama-Hokubu Medical Center, Tokyo, Japan
⁷ Department of Internal Medicine, Chiba University Graduate School of Medicine, Chiba, Japan
⁸ Department of Biostatistic, Epidemiology and Preventive Health Sciences, University of Tokyo, Tokyo, Japan
⁹ The Institute for Adult Diseases Asahi Life Foundation, Tokyo, Japan

Address correspondence and reprint requests to Nobuhiro Yamada, MD, PhD, Department of Internal Medicine, University of Tsukuba Institute of Clinical Medicine, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan 305-8575. E-mail: jdcstudy{at}md.tsukuba.ac.jp

Abbreviations: CHD, coronary heart disease • CVD, cardiovascular disease • JDCS, Japan Diabetes Complications Study • NCEP, National Cholesterol Education Program • WHO, World Health Organization

	INTRODUCTION

TOP INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS CONCLUSIONS References

 
We previously reported (1) the limited clinical significance for Japanese diabetic patients of the widely used World Health Organization (WHO) (2) and National Cholesterol Education Program (NCEP) (3) definitions of metabolic syndrome and suggested that an international definition of metabolic syndrome that was applicable regardless of ethnicity was necessary (1).

Recently, the International Diabetes Federation published a long-awaited new worldwide definition of metabolic syndrome (4) that is intended to be applicable to various ethnic groups. The new definition is similar to the NCEP definition (3) but has several important differences. Notably, most components of the new definition now include subjects who are receiving specific treatments for the abnormalities that comprise metabolic syndrome. Also, central obesity (defined by waist circumference with ethnic modification in its thresholds) has become a mandatory component in the new definition. In this report, we evaluated the predictive power of the new international definition for cardiovascular disease (CVD), as compared with that of previous definitions, in Japanese diabetic patients.

	RESEARCH DESIGN AND METHODS

TOP INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS CONCLUSIONS References

 
The Japan Diabetes Complications Study (JDCS) has been described in detail elsewhere (1, 5). The same dataset was used for evaluation so that the new definition of metabolic syndrome could be directly compared with the WHO and NCEP definitions (1–4). A total of 1,424 Japanese patients (771 men and 653 women, age 58.4 ± 7.4 years [means ± SD]) with previously diagnosed type 2 diabetes but without known CVD were followed for 8 years for coronary heart disease (CHD) and stroke events. Fatal and nonfatal CHD and stroke were defined as previously reported (1). The new International Diabetes Federation definition (4) was used with a recommended ethnic modification for Japanese subjects in relation to waist circumference (men 85 cm, women 90 cm). Since all of the subjects had diabetes, metabolic syndrome diagnosis was made in patients who met criteria for central obesity plus one or more of the following: increased triglycerides, increased blood pressure, or reduced HDL cholesterol (see Table 1 for detailed thresholds). Incidence rates in the two groups (with and without metabolic syndrome) were estimated under the Poisson assumption using person-year methods. Cox regression analysis was used to calculate the age-adjusted hazard ratio (HR) and 95% CI of metabolic syndrome risk factors with CHD, stroke, or both. The SAS software package (version 8.0; SAS Institute, Cary, NC) was used for all analyses. P < 0.05 was considered statistically significant.

	RESULTS

TOP INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS CONCLUSIONS References

The incidence (per 1,000 patient-years) of CHD (13.5 [with metabolic syndrome] vs. 8.1 [without metabolic syndrome] in men; 5.8 vs. 5.5 in women) or stroke (8.1 vs. 7.5 in men; 8.8 vs. 7.0 in women) did not differ significantly between subjects with or without metabolic syndrome. Age-adjusted HRs were calculated to determine whether the new metabolic syndrome definition or its components could predict cardiovascular events (Table 1). Patients diagnosed as having metabolic syndrome, even when subgrouped by therapeutic contents (oral hypoglycemic agents or insulin use), did not show significantly raised HRs for CHD, stroke, or both compared with subjects without metabolic syndrome. However, male patients with raised triglyceride levels and/or having specific treatment for this condition had a significantly increased risk of CHD (HR 2.93, P < 0.001) and combined CHD and stroke (1.96, P = 0.006), regardless of whether they had metabolic syndrome (Table 1).

	CONCLUSIONS

TOP INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS CONCLUSIONS References

 
Our previous analysis (1) showed that HRs for CVD in patients with WHO-defined metabolic syndrome were significantly elevated compared with HRs in subjects without metabolic syndrome (although the HR for CHD in male patients was not elevated). Diagnosis of metabolic syndrome by the NCEP definition was less predictive but still associated with a significantly elevated HR for CHD in male patients. However, metabolic syndrome diagnosis by the new definition was not predictive for CVD in either male or female patients in the same prospective setting. Therefore, the new definition did not improve the prediction of adverse cardiovascular events, and its clinical usefulness in Japanese diabetic patients is rather less than that of the existing definitions or of hypertriglyceridemia alone in male patients.

The indispensability of central obesity to the new definition was a major cause of the decrease in the prevalence of metabolic syndrome observed using the new definition. The fact that most patients with central obesity were classified as having metabolic syndrome revealed that metabolic syndrome diagnosis by the new definition was highly dependent on waist circumference when applied to Japanese diabetic subjects. It also denoted that most patients with central obesity had at least one other cardiovascular risk factor, suggesting a close relationship between central obesity and other cardiovascular risk factors. However, this combination was not necessarily associated with an increased risk of CVD in our patients. This latter observation led us to further evaluate the significance of waist circumference in our patients by modifying the threshold within the 65- and 105-cm range and recalculating the HRs. Interestingly, we could not find any thresholds associated with significantly elevated HRs for cardiovascular events in either male or female subjects (data not shown). Therefore, the new definition’s lower prediction power for CVD seemed to be derived from the indispensability of the waist circumference component.

To date, prospective trials examining the significance of metabolic syndrome as a predictor of CVD in diabetic patients (1, 6–9) have been inadequate (10, 11). Many important issues remain to be resolved. 1) Is the new definition of metabolic syndrome a good predictor of CVD in diabetic patients of differing ethnicities (12)? 2) Are there any other combinations of components (or different thresholds) that are better predictors of CVD in Asian diabetic patients (13–15)? 3) Is the concept of metabolic syndrome truly applicable or relevant to diabetic patients in general? Investigations of these issues would aid the screening of diabetic patients at especially high risk of CVD, as well as inform and direct ethnic group–specific management of diabetes (16–19).

	Acknowledgments

 
The JDCS was financially supported by the Ministry of Health, Labor, and Welfare of Japan.

	Footnotes

 
^* Members of the JDCS Study Group have been listed previously (1).

A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

Received for publication July 20, 2005. Accepted for publication September 24, 2005.

	References

TOP INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS CONCLUSIONS References

 

1. Sone H, Mizuno S, Fujii H, Yoshimura Y, Yamasaki Y, Ishibashi S, Katayama S, Saito Y, Ito H, Ohashi Y, Akanuma Y, Yamada N: Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in Asian diabetic patients? Analysis from the Japan Diabetes Complications Study. Diabetes Care 28:1463–1471, 2005[Abstract/Free Full Text]
   
2. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Org., 1999
   
3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486–2497, 2001[Free Full Text]
   
4. The International Diabetes Federation: The IDF consensus worldwide definition of metabolic syndrome [article online], 2005. Available from http://www.idf.org/webdata/docs/IDF_metasyndrome_definition.pdf. Accessed 10 July 2005
   
5. Sone H, Katagiri A, Ishibashi S, Abe R, Saito Y, Murase T, Yamashita H, Yajima Y, Ito H, Ohashi Y, Akanuma Y, Yamada N, the JD Study Group: Effects of lifestyle modifications on patients with type 2 diabetes: the Japan Diabetes Complications Study (JDCS) study design, baseline analysis and three year-interim report. Horm Metab Res 34:509–515, 2002[Medline]
   
6. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care24:683–689, 2001
   
7. Gimeno Orna JA, Lou Arnal LM, Molinero Herguedas E, Boned Julian B, Portilla Cordoba DP: Metabolic syndrome as a cardiovascular risk factor in patients with type 2 diabetes. Rev Esp Cardiol 57:507–513, 2004 [article in Spanish][Medline]
   
8. Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Gemma L, Santi L, Bonadonna RC, Muggeo M: Metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabet Med 21:52–58, 2004[Medline]
   
9. Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Runzo C, Prina Cerai S, Pagano G, Cavallo-Perin P: Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetes Care 27:2689–2694, 2004[Abstract/Free Full Text]
   
10. Ford ES: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28:1769–1778, 2005[Abstract/Free Full Text]
    
11. Reynolds K, Muntner P, Fonseca V: Metabolic syndrome: underrated or underdiagnosed? Diabetes Care 28:1831–1832, 2005[Free Full Text]
    
12. Jorgensen ME, Borch-Johnsen K: The metabolic syndrome: is one global definition possible? Diabet Med 21:1064–1065, 2004[Medline]
    
13. Tan CE, Ma S, Wai D, Chew SK, Tai ES: Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 27:1182–1186, 2004[Abstract/Free Full Text]
    
14. Mandavilli A, Cyranoski D: Asia’s big problem. Nat Med 10:325–327, 2004[Medline]
    
15. Liu J, Hong Y, D’Agostino RB Sr, Wu Z, Wang W, Sun J, Wilson PW, Kannel WB, Zhao D: Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA 291:2591–2599, 2004[Abstract/Free Full Text]
    
16. Sone H, Ito H, Ohashi Y, Akanuma Y, Yamada N, the Japan Diabetes Complication Study Group: Obesity and type 2 diabetes in Japanese patients (Letter). Lancet 361:85, 2003[Medline]
    
17. Sone H, Yamada N, Mizuno S, Aida R, Ohashi Y: Alcohol use and diabetes mellitus (Letter). Ann Intern Med 141:408–409, 2004[Free Full Text]
    
18. Sone H, Yoshimura Y, Ito H, Ohashi Y, Yamada N, the Japan Diabetes Complications Study Group: Energy intake and obesity in Japanese patients with type 2 diabetes (Letter). Lancet 363:248–249, 2004[Medline]
    
19. Sone H, Mizuno S, Yamada N: Vascular risk factors and diabetic neuropathy (Letter). N Engl J Med 352:1925–1927, 2005[Free Full Text]
    

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				S.H. Song and C.A. Hardisty Diagnosing metabolic syndrome in type 2 diabetes: does it matter? QJM, June 1, 2008; 101(6): 487 - 491. [Abstract] [Full Text] [PDF]

				R Kawasaki, J M Tielsch, J J Wang, T Y Wong, P Mitchell, Y Tano, M Tominaga, T Oizumi, M Daimon, T Kato, et al. The metabolic syndrome and retinal microvascular signs in a Japanese population: the Funagata study Br. J. Ophthalmol., February 1, 2008; 92(2): 161 - 166. [Abstract] [Full Text] [PDF]

				T. Ninomiya, M. Kubo, Y. Doi, K. Yonemoto, Y. Tanizaki, M. Rahman, H. Arima, K. Tsuryuya, M. Iida, and Y. Kiyohara Impact of Metabolic Syndrome on the Development of Cardiovascular Disease in a General Japanese Population: The Hisayama Study Stroke, July 1, 2007; 38(7): 2063 - 2069. [Abstract] [Full Text] [PDF]

				P. C. Tong, A. P. Kong, W.-Y. So, X. Yang, C.-S. Ho, R. C. Ma, R. Ozaki, C.-C. Chow, C. W. Lam, J. C.N. Chan, et al. The Usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III Definitions of the Metabolic Syndrome in Predicting Coronary Heart Disease in Subjects With Type 2 Diabetes Diabetes Care, May 1, 2007; 30(5): 1206 - 1211. [Abstract] [Full Text] [PDF]

				R. S. Beaser and P. Levy A Work in Progress, but a Useful Construct Circulation, April 3, 2007; 115(13): 1812 - 1818. [Full Text] [PDF]

				E. Oda Incidence of Type 2 Diabetes in Individuals With Central Obesity in a Rural Japanese Population: The Tanno and Sobetssu Study: Response to Ohnishi et al. Diabetes Care, August 1, 2006; 29(8): 1988 - 1989. [Full Text] [PDF]

				H. Sone, S. Tanaka, Y. Ohashi, and N. Yamada Cut Points of Waist Circumference: Response to Oda Diabetes Care, May 1, 2006; 29(5): 1189 - 1189. [Full Text] [PDF]

				E. Oda Cut Points of Waist Circumference: Response to Sone and Colleagues Diabetes Care, May 1, 2006; 29(5): 1188 - 1189. [Full Text] [PDF]

This Article Extract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sone, H. Search for Related Content PubMed PubMed Citation Articles by Sone, H. Social Bookmarking                What's this?